Adverse Associated with the Cosmetic Usage of Botulinum Toxin
Main Article Content
Abstract
Botulinum toxin, the primary cause of botulism, is used in therapeutic environments for several objectives. Botulinum toxin injections effectively treat cosmetic concerns caused or exacerbated by muscular contractions by regulating local neurotransmission. The effects of therapy are temporary; noticeable muscular recovery often occurs many months after treatment, as shown in clinical settings. Improper placement of injections or the spread of toxins to undesired areas may lead to significant muscle weakness, perhaps causing temporary deformity or functional issues. Therapeutic techniques may be used to fix visual problems including eyelid ptosis and a puzzling brow. Under different conditions, advancement relies on the gradual decrease in the effectiveness of the botulinum toxin.
Introduction
Botulinum toxin is a neurotoxin derived from the bacterium Clostridium botulinum, which is responsible for causing botulism. It is administered by injections and acts as a neuromodulator. Botulinum toxin hampers or immobilizes skeletal muscle by obstructing the transfer of signals between nerve endings and muscle fibers. Originally used for medicinal applications, the administration of botulinum toxin by injection has since gained significant popularity as a prominent method for facial rejuvenation.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Nicoletti, M. M., Anatriello, A., Liguori, V., Cantone, A., di Mauro, G., Izzo, I., ... & Scavone, C. (2023). Skin toxicities associated with botulin toxin injection for aesthetic procedures: data from the European spontaneous reporting system. Pharmaceuticals, 16(11), 1611.
II. de Oliveira, A. C. C., Leite, S. S., Brito, F. D. Q., da Silva, A. R. M., Amorim, M. T., Carneiro, A. M. F., ... & Arruda, J. E. G. (2024). Adverse events related to botulinum toxin type A, reported in Brazil between 2019 and 2022. Caderno Pedagógico, 21(7), e5823-e5823.
III. Samizadeh, S., & De Boulle, K. (2023). Complications of toxins and fillers in facial aesthetics. Primary Dental Journal, 12(3), 65-72.
IV. Michon, A. (2023). Botulinum toxin for cosmetic treatments in young adults: An evidence‐based review and survey on current practice among aesthetic practitioners. Journal of Cosmetic Dermatology, 22(1), 128-139.
V. Glaser, K., & Glaser, D. A. (2023). Cosmetic Uses of Botulinum Neurotoxins for the Upper Face. Manual of Botulinum Toxin Therapy, 188.
VI. Li, Y., Zheng, Q., Lin, J., Su, X., Zhuang, J., Wei, Q., & Hu, J. (2024). Mild Allergic Reactions after Botulinum Toxin Injection: A Case Series and Literature Review. Plastic and Reconstructive Surgery–Global Open, 12(5), e5845.
VII. Lipham, W. J., & Melicher, J. S. (2024). What Is Botulinum Toxin and How Does It Work?. In Cosmetic and clinical applications of Botox and dermal fillers (pp. 5-10). CRC Press.
VIII. Richardson, J., & Viviano, S. (2024). From Beauty to Botulism: A Case Report Highlighting the Rare Risk of Botox Administration. Cureus, 16(2).
IX. Karcioglu, O., Akman, C., & Atnis, I. (2024). Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril?. Current Pharmaceutical Design, 30(8), 578-588.
X. Mukherjee, J., Naresh, V., Krishna, A., Boggula, N., & Rao, T. R. (2023). Botox Treatment: A Comprehensive Review. Asian Journal of Medicine and Health, 21(11), 349-358.
XI. Haney, B. (2024). Neurotoxin Adverse Reactions. In Aesthetic Procedures: Nurse Practitioner's Guide to Cosmetic Dermatology (pp. 149-157). Cham: Springer International Publishing.